These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


144 related items for PubMed ID: 9558908

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine.
    Zinzani PL, Tani M, Marchi E, Stefoni V, Alinari L, Musuraca G, Gabriele A, Pileri S, Baccarani M.
    Haematologica; 2004 Mar; 89(3):309-13. PubMed ID: 15020269
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2-deoxycoformycin and prediction of early relapse.
    Tallman MS, Hakimian D, Kopecky KJ, Wheaton S, Wollins E, Foucar K, Cassileth PA, Habermann T, Grever M, Rowe JM, Peterson LC.
    Clin Cancer Res; 1999 Jul; 5(7):1665-70. PubMed ID: 10430066
    [Abstract] [Full Text] [Related]

  • 9. [Successful ambulatory treatment of patients with hairy-cell leukemia using one cycle of the purine analog cladribine. 'Hemato-oncologic volwassen Nederland' (HOVON) Study Group].
    Raemaekers JM, van 't Veer MB, Bogman MJ.
    Ned Tijdschr Geneeskd; 1996 Aug 03; 140(31):1600-4. PubMed ID: 8768814
    [Abstract] [Full Text] [Related]

  • 10. [Subcutaneous therapy of hairy cell leukemia with 2-chlorodeoxyadenosine].
    Nielsen OJ, Hippe E, Priø TK, Juliusson G.
    Ugeskr Laeger; 1994 Apr 18; 156(16):2407-9. PubMed ID: 7912015
    [Abstract] [Full Text] [Related]

  • 11. Retrospective analysis of 34 cases of hairy cell leukemia treated with interferon-alpha and/or 2-chlorodeoxyadenosine.
    Zaja F, Fanin R, Silvestri F, Russo D, Infanti L, Baccarani M.
    Haematologica; 1997 Apr 18; 82(4):468-70. PubMed ID: 9299866
    [Abstract] [Full Text] [Related]

  • 12. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland.
    Robak T, Błasińska-Morawiec M, Błoński J, Hellmann A, Hałaburda K, Konopka L, Kotlarek-Haus S, Potoczek S, Hansz J, Dmoszyńska A, Urasiński I, Zdziarska B, Dwilewicz-Trojaczek J, Hołowiecki J, Skotnicki AB.
    Eur J Haematol; 1999 Jan 18; 62(1):49-56. PubMed ID: 9918312
    [Abstract] [Full Text] [Related]

  • 13. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine.
    Piro LD, Carrera CJ, Carson DA, Beutler E.
    N Engl J Med; 1990 Apr 19; 322(16):1117-21. PubMed ID: 1969613
    [Abstract] [Full Text] [Related]

  • 14. Treatment of patients with hairy cell leukemia with 2-chloro-2'-deoxyadenosine (2-CdA).
    Robak T, Krykowski E, Błasińska-Morawiec M, Urbańska-Ryś H.
    Arch Immunol Ther Exp (Warsz); 1994 Apr 19; 42(1):25-9. PubMed ID: 7503629
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Successful treatment with cladribine for hypoplastic hairy cell leukemia after long-term neutropenia].
    Sakai R, Yamazaki E, Sakamoto H, Kanamori H, Ishigatsubo Y.
    Rinsho Ketsueki; 2005 Nov 19; 46(11):1187-90. PubMed ID: 16440801
    [Abstract] [Full Text] [Related]

  • 18. Successful treatment of patients with hairy cell leukemia (HCL) using a single cycle of 2-chloro-2'-deoxyadenosine (CdA).
    Jehn U, Gawaz M, Grunewald R, Hill W, Lorenz B, Stôtzer O.
    Anticancer Res; 1993 Nov 19; 13(5C):1809-14. PubMed ID: 7903521
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years.
    Else M, Ruchlemer R, Osuji N, Del Giudice I, Matutes E, Woodman A, Wotherspoon A, Swansbury J, Dearden C, Catovsky D.
    Cancer; 2005 Dec 01; 104(11):2442-8. PubMed ID: 16245328
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.